Gene expression profiles of breast biopsies from healthy women identify a group with claudin-low features

BMC Medical Genomics

Volumn 4, Issue , 2011, Pages

  Haakensen, Vilde D ^a,b   Lingjærde, Ole ^c   Lüders, Torben ^d   Riis, Margit ^d,e   Prat, Aleix ^f   Troester, Melissa A ^g   Holmen, Marit M ^a   Frantzen, Jan ^h   Romundstad, Linda ⁱ   Navjord, Dina ^j   Bukholm, Ida K ^b,d,e   Johannesen, Tom B ^k   Perou, Charles M ^f   Ursin, Giske ^c,k,l   Kristensen, Vessela N ^a,b,d   Børresen Dale, Anne Lise ^a,b   Helland, Åslaug ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^e Akerhus University Hospital   (Norway)

^f IL   (United States)

^g UNIVERSITY OF NORTH CAROLINA   (United States)

^h UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

ⁱ Sykehuset Buskerud HF   (Norway)

^j Innlandet Hospital Trust   (Norway)

^k CANCER REGISTRY OF NORWAY   (Norway)

^l UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

more..

Author keywords

claudin low; Gene expression; hierarchical clustering; normal breast tissue

Indexed keywords

CLAUDIN;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST CELL; CANCER CLASSIFICATION; CANCER STEM CELL; CLINICAL ARTICLE; CLUSTER ANALYSIS; CONTROLLED STUDY; FAMILY HISTORY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MESENCHYME CELL; MYOEPITHELIUM CELL; PRIORITY JOURNAL; STROMA CELL; BIOPSY; BODY MASS; BREAST; BREAST TUMOR; CYTOLOGY; GENETICS; HEALTH; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; BIOPSY; BODY MASS INDEX; BREAST; BREAST NEOPLASMS; CLAUDINS; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; HEALTH; HUMANS; MIDDLE AGED;

EID: 80055043837     PISSN: None     EISSN: 17558794     Source Type: Journal    
DOI: 10.1186/1755-8794-4-77     Document Type: Article

References (39)

1. In situ analyses of genome instability in breast cancer. Chin K, de Solorzano CO, Knowles D, Jones A, Chou W, Rodriguez EG, Kuo WL, Ljung BM, Chew K, Myambo K, et al. Nat Genet 2004 36 984 988 10.1038/ng1409 15300252 (Pubitemid 39167495)
2. Connecting chromosomes, crisis, and cancer. Maser RS, DePinho RA, Science 2002 297 565 569 10.1126/science.297.5581.565 12142527 (Pubitemid 34815334)
3. Cancer initiation and progression: involvement of stem cells and the microenvironment. Tysnes BB, Bjerkvig R, Biochim Biophys Acta 2007 1775 283 297 17374555 (Pubitemid 46901154)
4. Molecular portraits of human breast tumours. Perou CM, Sorlie T, Eisen MB, van de RM, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al. Nature 2000 406 747 752 10.1038/35021093 10963602
5. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de RM, Jeffrey SS, et al. Proc Natl Acad Sci USA 2001 98 10869 10874 10.1073/pnas.191367098 11553815 (Pubitemid 32878711)
6. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, sselin-Labat ML, Gyorki DE, Ward T, Partanen A, et al. Nat Med 2009 15 907 913 10.1038/nm.2000 19648928
7. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu Z, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, et al. Genome Biol 2007 8 76 10.1186/gb-2007-8-5-r76 17493263 (Pubitemid 351902765)
8. Mammary development meets cancer genomics. Prat A, Perou CM, Nat Med 2009 15 842 844 10.1038/nm0809-842 19661985
9. Epithelial stem cells and their niche: there's no place like home. Rizvi AZ, Wong MH, Stem Cells 2005 23 150 165 10.1634/stemcells.2004-0096 15671140 (Pubitemid 40239512)
10. Targeting Breast Cancer Stem Cells. Liu S, Wicha MS, J Clin Oncol 2010
11. The cancer stem cell hypothesis: in search of definitions, markers, and relevance. Shipitsin M, Polyak K, Lab Invest 2008
12. Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer. Jones C, Mackay A, Grigoriadis A, Cossu A, Reis-Filho JS, Fulford L, Dexter T, Davies S, Bulmer K, Ford E, et al. Cancer Res 2004 64 3037 3045 10.1158/0008-5472.CAN-03-2028 15126339 (Pubitemid 38581402)
13. Expression profiling of epithelial plasticity in tumor progression. Jechlinger M, Grunert S, Tamir IH, Janda E, Ludemann S, Waerner T, Seither P, Weith A, Beug H, Kraut N, Oncogene 2003 22 7155 7169 10.1038/sj.onc.1206887 14562044 (Pubitemid 37378548)
14. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Raouf A, Zhao Y, To K, Stingl J, Delaney A, Barbara M, Iscove N, Jones S, McKinney S, Emerman J, et al. Cell Stem Cell 2008 3 109 118 10.1016/j.stem.2008.05.018 18593563
15. The prognostic role of a gene signature from tumorigenic breast-cancer cells. Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K, Clarke MF, N Engl J Med 2007 356 217 226 10.1056/NEJMoa063994 17229949 (Pubitemid 46143225)
16. Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue. Chen DT, Nasir A, Culhane A, Venkataramu C, Fulp W, Rubio R, Wang T, Agrawal D, McCarthy SM, Gruidl M, et al. Breast Cancer Res Treat 2009
17. Gene expression signatures of morphologically normal breast tissue identify basal-like tumors. Finak G, Sadekova S, Pepin F, Hallett M, Meterissian S, Halwani F, Khetani K, Souleimanova M, Zabolotny B, Omeroglu A, et al. Breast Cancer Res 2006 8 58 10.1186/bcr1608 17054791 (Pubitemid 44804003)
18. Molecular signatures suggest a major role for stromal cells in development of invasive breast cancer. Casey T, Bond J, Tighe S, Hunter T, Lintault L, Patel O, Eneman J, Crocker A, White J, Tessitore J, et al. Breast Cancer Res Treat 2008
19. Evidence for a stem cell hierarchy in the adult human breast. Villadsen R, Fridriksdottir AJ, Ronnov-Jessen L, Gudjonsson T, Rank F, LaBarge MA, Bissell MJ, Petersen OW, J Cell Biol 2007 177 87 101 10.1083/jcb.200611114 17420292 (Pubitemid 46588404)
20. Disease-specific genomic analysis: identifying the signature of pathologic biology. Nicolau M, Tibshirani R, Borresen-Dale AL, Jeffrey SS, Bioinformatics 2007 23 957 965 10.1093/bioinformatics/btm033 17277331 (Pubitemid 47050582)
21. Molecular constitution of breast but not other reproductive tissues is rich in growth promoting molecules: a possible link to highest incidence of tumor growths. Poola I, Abraham J, Marshalleck JJ, Yue Q, Fu SW, Viswanath L, Sharma N, Hill R, Dewitty RL, Bonney G, FEBS Lett 2009 583 3069 3075 10.1016/j.febslet.2009.08.021 19698714
22. Exonic expression profiling of breast cancer and benign lesions: a retrospective analysis. Andre F, Michiels S, Dessen P, Scott V, Suciu V, Uzan C, Lazar V, Lacroix L, Vassal G, Spielmann M, et al. Lancet Oncol 2009 10 381 390 10.1016/S1470-2045(09)70024-5 19249242
23. Expression levels of uridine 5'-diphospho-glucuronosyltransferase genes in breast tissue from healthy women are associated with mammographic density. Haakensen VD, Biong M, Lingjaerde OC, Holmen MM, Frantzen JO, Chen Y, Navjord D, Romundstad L, Luders T, Bukholm IK, et al. Breast Cancer Res 2010 12 65 10.1186/bcr2632 20799965
24. The detection of changes in mammographic densities. Ursin G, Astrahan MA, Salane M, Parisky YR, Pearce JG, Daniels JR, Pike MC, Spicer DV, Cancer Epidemiol Biomarkers Prev 1998 7 43 47 9456242 (Pubitemid 28087141)
25. Estimating the number of clusters in a data set via the gap statistic. Tibshirani R, Walther G, Hastie T, J R Statist Soc B 2001 63 411 423 10.1111/1467-9868.00293
26. Significance analysis of microarrays applied to the ionizing radiation response. Tusher VG, Tibshirani R, Chu G, Proc Natl Acad Sci USA 2001 98 5116 5121 10.1073/pnas.091062498 11309499 (Pubitemid 32397092)
27. Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Prat A, Parker JS, Karginova O, Fan C, Livasy C, Herschkowitz JI, He X, Perou CM, Breast Cancer Res 2010 12 68 10.1186/bcr2635 20813035
28. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Neve RM, Chin K, Fridlyand J, Yeh J, Baehner FL, Fevr T, Clark L, Bayani N, Coppe JP, Tong F, et al. Cancer Cell 2006 10 515 527 10.1016/j.ccr.2006.10.008 17157791 (Pubitemid 44854747)
29. Adjustment of systematic microarray data biases. Benito M, Parker J, Du Q, Wu J, Xiang D, Perou CM, Marron JS, Bioinformatics 2004 20 105 114 10.1093/bioinformatics/btg385 14693816 (Pubitemid 38094234)
30. Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes. Parker JS, Mullins M, Cheang MCU, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, et al. J Clin Oncol 2009 27 1160 1167 10.1200/JCO.2008.18.1370 19204204
31. Molecular definition of breast tumor heterogeneity. Shipitsin M, Campbell LL, Argani P, Weremowicz S, Bloushtain-Qimron N, Yao J, Nikolskaya T, Serebryiskaya T, Beroukhim R, Hu M, et al. Cancer Cell 2007 11 259 273 10.1016/j.ccr.2007.01.013 17349583 (Pubitemid 46349843)
32. Gene expression patterns in the human breast after pregnancy. Asztalos S, Gann PH, Hayes MK, Nonn L, Beam CA, Dai Y, Wiley EL, Tonetti DA, Cancer Prev Res (Phila Pa) 2010 3 301 311 10.1158/1940-6207.CAPR-09-0069
33. "Destemming" cancer stem cells. Hill RP, Perris R, J Natl Cancer Inst 2007 99 1435 1440 10.1093/jnci/djm136 17895479
34. Of microenvironments and mammary stem cells. LaBarge MA, Petersen OW, Bissell MJ, Stem Cell Rev 2007 3 137 146 10.1007/s12015-007-0024-4 17873346 (Pubitemid 350129716)
35. The stem cell niche in health and malignancy. Burness ML, Sipkins DA, Semin Cancer Biol 2010 20 107 115 10.1016/j.semcancer.2010.05.006 20510363
36. The epithelial-mesenchymal transition generates cells with properties of stem cells. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al. Cell 2008 133 704 715 10.1016/j.cell.2008.03.027 18485877 (Pubitemid 351636299)
37. Mammary field cancerization: molecular evidence and clinical importance. Heaphy C, Griffith J, Bisoffi M, Breast Cancer Research and Treatment 2009 118 229 239 10.1007/s10549-009-0504-0 19685287
38. Gene expression in histologically normal epithelium from breast cancer patients and from cancer-free prophylactic mastectomy patients shares a similar profile. Graham K, de las MA, Tripathi A, King C, Kavanah M, Mendez J, Stone M, Slama J, Miller M, Antoine G, et al. Br J Cancer 2010 102 1284 1293 10.1038/sj.bjc.6605576 20197764
39. Reliability and reproducibility of gene expression measurements using amplified RNA from laser-microdissected primary breast tissue with oligonucleotide arrays. King C, Guo N, Frampton GM, Gerry NP, Lenburg ME, Rosenberg CL, J Mol Diagn 2005 7 57 64 10.1016/S1525-1578(10)60009-8 15681475 (Pubitemid 40310166)